BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2057398)

  • 1. von Hippel-Lindau disease: a genetic condition predisposing tumor formation.
    Martz CH
    Oncol Nurs Forum; 1991 Apr; 18(3):545-51. PubMed ID: 2057398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
    Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
    J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
    Richard S;
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
    Hes FJ; van der Luijt RB
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [von Hippel-Lindau syndrome: molecular diagnosis of two Lebanese families and analysis of the genotype-phenotype correlation].
    Medlej-Hashim M; Leclercq A; Salem N; Moukarzel M; Merhej S; Pigny P; Megarbane A
    J Med Liban; 2004; 52(1):51-4. PubMed ID: 15881703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
    Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
    Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
    Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of the von Hippel-Lindau disease in three spanish families].
    Villar Gómez de las Heras K
    An Med Interna; 2002 Jul; 19(7):352-6. PubMed ID: 12224143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
    Richard S; Beroud C; Joly D; Chretien Y; Benoit G
    Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
    Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
    Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of von Hippel-Lindau-associated kidney cancer.
    Grubb RL; Choyke PL; Pinto PA; Linehan WM; Walther MM
    Nat Clin Pract Urol; 2005 May; 2(5):248-55. PubMed ID: 16474836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [von Hippel-Lindau disease].
    Metso S
    Duodecim; 2014; 130(18):1867-73. PubMed ID: 25558629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.
    Shah DR; Hoeksema J; Korbet SM
    Clin Nephrol; 2000 Mar; 53(3):216-21. PubMed ID: 10749302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and management of von Hippel-Lindau disease.
    Lesho EP
    Am Fam Physician; 1994 Nov; 50(6):1269-72. PubMed ID: 7942425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of echography in the diagnosis, screening, and follow-up of patients with von Hippel-Lindau syndrome].
    De Thomasis R; Nicolai M; Menna C; Longeri D; Palucci Q; Tenaglia R
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):207-10. PubMed ID: 9162363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.